Causal Role of Delta and Theta Oscillations in Hierarchical Cognitive Control

Description

The purpose of this clinical trial is to evaluate the effect of rhythmic transcranial magnetic stimulation (TMS) delivered at delta (2.2 Hz) or theta (6.5 Hz) frequency on cognitive control. This study aims to explore how targeted stimulation at delta and theta frequencies modulates brain activity to enhance cognitive performance in healthy populations.

Conditions

Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this clinical trial is to evaluate the effect of rhythmic transcranial magnetic stimulation (TMS) delivered at delta (2.2 Hz) or theta (6.5 Hz) frequency on cognitive control. This study aims to explore how targeted stimulation at delta and theta frequencies modulates brain activity to enhance cognitive performance in healthy populations.

Causal Role of Delta and Theta Oscillations in Hierarchical Cognitive Control

Causal Role of Delta and Theta Oscillations in Hierarchical Cognitive Control

Condition
Rhythmic Transcranial Magnetic Stimulation (rTMS) Effect on Hierarchical Cognitive Control
Intervention / Treatment

-

Contacts and Locations

Tallahassee

Florida State University Psychology Dept Bldg A411, Tallahassee, Florida, United States, 32304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participants must be between the ages of 18 and 35.
  • * Must be able to provide informed consent.
  • * Must have normal or corrected-to-normal vision.
  • * Participants must be right-handed.
  • * Willingness to comply with all study procedures and availability for the study duration.
  • * Proficiency in speaking and understanding English.
  • * Must not be color-blind
  • * Current treatment for ADHD/ADD.
  • * History of neurological disorders, including but not limited to the following specified conditions
  • * Epilepsy or seizures (excluding childhood febrile seizures).
  • * Dementia, Parkinson's disease, multiple sclerosis, cerebral aneurysm, or brain tumors.
  • * History of stroke or traumatic brain injury.
  • * Medical conditions or treatments that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, or renal impairment).
  • * Prior brain surgery or presence of brain devices/implants (e.g., cochlear implants or aneurysm clips).
  • * Females who are pregnant or breastfeeding.
  • * Use of specific medications, including but not limited to ADHD medications or benzodiazepines, which may interfere with EEG measurements or task performance
  • * Any condition that, in the opinion of the investigator, increases risk or hinders full compliance with the study.

Ages Eligible for Study

18 Years to 35 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Florida State University,

Study Record Dates

2025-12